Program

Round Table Discussion

Date	Time	Session Title	Chairpersons	Agenda
July 12th	9:00-10:20	1. Epidemiology and Clinical Diagnosis	Isao Hamaguchi Lloyd Einsiedel Graham Taylor	1. Current status of infection and transmission 2. Clinical epidemiology 3. Risk evaluation
	10:20-10:40	Coffee Break
	10:40-12:00	2. Virology	Renaud Mahieux Masao Matsuoka Anne Van den Broeke	1. Function of viral gennes 2. Viral immunology 3. Proviral insertion
July 13th	9:00-10:20	3. Pathogenesis of associated diseases	Charles Bangham Steven Jacobson Toshiki Watanabe	1. Genomic abonormalities 2. Epigenetic abnormalities 3. Gene expression
	10:20-10:40	Coffee Break
	10:40-12:00	4. Prevention and Therapy	Yoshi Yamano Kunihiro Tsukasaki Olivier Hermine	1. Drug discovery and Preclinical studies 2. Clinical trials 3. Guidelines for HAM/TSP and ATL

			Speaker	Title of speech
July 12th	13:30-13:55	1	Antoine Gessain	Epidemiology and Origin of HTLV-1 and Related Viruses Infection
	13:55-14:20	2	Lloyd Einsiedel	THE HUMAN T LYMPHOTROPIC VIRUS TYPE 1 SUBTYPE C: A MAJOR CAUSE OF MORBIDITY AND MORTALITY FOR INDIGENOUS AUSTRALIANS
	14:20- 14:45	3	Veffa Franchini	Do biological differences exist between HTLV-1A and HTLV-1C?
	14:45-15:10	4	Eduardo Gotuzzo	What we have learned from Peru Cohort
	15:10-15:30		Coffee Break
	15:30:-15:55	5	Renaud Mahieux	Primate model for studying HTLV-1 infection
	15:55:-16:20	6	Charles Bangham	HTLV-1: pathogenesis and regulation of latency
	16:20-16:45	7	Yoshihisa Yamano	Treatment of HAM/TSP
	16:45-17:10	8	Makoto Yamagishi	Development of an epigenetic drug against ATL
	18:00		Banquet